Trials / Completed
CompletedNCT05940129
Women and Child, Safety, Health, and Empowerment
Integrating Maternal, Fetal, Newborn or Infant Safety in Antenatal and Post-natal Care Services for Rural and Tribal Women in India
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (actual)
- Sponsor
- Johns Hopkins University · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Gender-based violence (GBV) (including homicide) is one of the leading causes of maternal and child (fetus, newborn or infant) mortality and morbidity in limited resource settings such as India. This study is evaluating the feasibility, acceptability and preliminary efficacy of WC-SHE (Women and Children-Safety, Health and Empowerment) intervention developed to promote health and safety outcomes of mother and children in rural and/or tribal regions in India. The aim will be to refine, optimize and standardize the WC-SHE intervention and its added components, develop fidelity measures, conduct a feasibility and acceptability evaluation of the intervention and implementation procedures as well as examine preliminary efficacy outcomes of WC-SHE.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Women and Child, Safety, Health and Empowerment (WC-SHE) | The WC-SHE component includes a risk assessment and tailored safety planning for women in domestic violence relationships. In addition, the component involves one-on-one education with husbands and in-laws. The economic empowerment component is designed to support women and their husbands in economic empowerment activities. The advocacy arm involves community education of husbands and in-laws, advocacy support by a support committee comprised of multidisciplinary professionals and phone support by women community resource persons |
Timeline
- Start date
- 2022-10-21
- Primary completion
- 2023-11-30
- Completion
- 2023-11-30
- First posted
- 2023-07-11
- Last updated
- 2023-12-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05940129. Inclusion in this directory is not an endorsement.